Recombinant Rat Kcnc1 is a laboratory-produced version of the voltage-gated potassium channel Kv3.1, encoded by the Kcnc1 gene. It facilitates high-frequency action potentials in fast-spiking neurons and is essential for regulating neuronal excitability . Recombinant expression enables biochemical, structural, and functional studies without requiring native tissue extraction .
Recombinant Rat Kcnc1 is produced using multiple expression systems:
Mammalian systems (e.g., HEK293) are preferred for proper glycosylation and membrane localization .
Kcnc1 channels enable rapid repolarization of action potentials in fast-spiking GABAergic interneurons and auditory neurons . Key functional attributes include:
Voltage Sensitivity: Activates at depolarized potentials (~−20 mV) .
Kinetics: Ultra-rapid activation and deactivation, supporting high-frequency firing .
Pathway Involvement:
Recombinant Rat Kcnc1 is utilized in:
Electrophysiology: Patch-clamp studies to characterize current density and kinetics .
Disease Modeling: Investigating developmental epileptic encephalopathies caused by Kcnc1 variants .
Drug Screening: Identifying modulators of Kv3.1 for neurological disorders .
Trafficking Deficits: The A421V variant reduces membrane localization by ~50%, impairing neuronal excitability .
Epilepsy Link: Heterozygous Kcnc1 mutations cause progressive myoclonic epilepsy via disrupted inhibitory neurotransmission .
Therapeutic Targets: Kv3.1 enhancers (e.g., AUT1) are under investigation for myoclonus and ataxia .